Keywords: مهار کننده های مستقیم ترومبین; Anticoagulants; Asian patients; atrial fibrillation; direct thrombin inhibitors; factor Xa inhibitors;
مقالات ISI مهار کننده های مستقیم ترومبین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهار کننده های مستقیم ترومبین; Laboratory monitoring; Prothrombin complex concentrates; Specific reversal agents; Factor Xa inhibitors; Direct thrombin inhibitors;
Keywords: مهار کننده های مستقیم ترومبین; Anticoagulation; Reversal of anticoagulation; Warfarin; Vitamin K; Fresh frozen plasma; Prothrombin complex concentrates; Direct thrombin inhibitors; Factor Xa inhibitors;
Keywords: مهار کننده های مستقیم ترومبین; Anticoagulation; Coumadin; Direct thrombin inhibitors; Factor Xa inhibitors; Antiplatelet; Neuraxial; Regional;
Keywords: مهار کننده های مستقیم ترومبین; Apixaban; Dabigatran; Direct thrombin inhibitors; Edoxaban; Factor Xa inhibitors; Rivaroxaban;
Keywords: مهار کننده های مستقیم ترومبین; Bivalirudin; Heparin; Angina; Acute coronary syndrome; Non-ST-elevation myocardial infarction; ST-elevation myocardial infarction; ACS; acute coronary syndromes; STEMI; ST-segment elevation myocardial infarction; NSTEMI; non-ST-segment elevation myocardia
Keywords: مهار کننده های مستقیم ترومبین; Oral anticoagulation; Prothrombin complex concentrates; Direct thrombin inhibitors; Xa antagonists; Platelets;
An optimized dRVVT-based assay to estimate the intensity of anticoagulation in patients treated with direct oral anticoagulants
Keywords: مهار کننده های مستقیم ترومبین; Blood coagulation; Direct factor Xa inhibitors; Direct thrombin inhibitors; Drug monitoring; Russell's viper venom;
Controversies in the Management of ST Elevation Myocardial Infarction
Keywords: مهار کننده های مستقیم ترومبین; ST elevation myocardial infarction (STEMI); Primary percutaneous coronary intervention (primary PCI); Fibrinolysis; Bivalirudin; Direct thrombin inhibitors; Unfractionated heparin (UFH);
Risk and benefit of direct oral anticoagulants or PAR-1 antagonists in addition to antiplatelet therapy in patients with acute coronary syndrome
Keywords: مهار کننده های مستقیم ترومبین; Acute coronary syndrome; Direct Xa inhibitors; Direct thrombin inhibitors; PAR-1 antagonist;
The paradoxical antifibrinolytic effect of dabigatran and argatroban in the presence of soluble thrombomodulin is unrelated to protein C-dependent increase of thrombin generation
Keywords: مهار کننده های مستقیم ترومبین; AT; antithrombin; AUC; area under the curve; DMSO; dimethyl sulfoxide; αPC; monoclonal antibody against human protein C; DTIs; direct thrombin inhibitors; ETP; endogenous thrombin potential; PC; protein C; PTCI; potato tuber carboxypeptidase inhibitor; r
Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT) - findings from the GerHIT multi-centre registry study
Keywords: مهار کننده های مستقیم ترومبین; A; argatroban; aPTT; activated partial thromboplastin time; BMI; body-mass index; CRF; case report forms; CRO; Contract Research Organisation; D; danaparoid; DIC; disseminated intravascular coagulation; DTI; direct thrombin inhibitors; DVT; deep vein thro
Dabigatran: A Primer for Neurosurgeons
Keywords: مهار کننده های مستقیم ترومبین; Anticoagulants; Benzimidazoles; Blood coagulation; Direct thrombin inhibitors; Intracranial hemorrhages; Perioperative periodaPCC, Activated prothrombin complex concentrate; aPTT, Activated partial thromboplastin time; CrCl, Creatinine clearance; FDA, U.S
Management of Anticoagulation in the Critically Ill Patient
Keywords: مهار کننده های مستقیم ترومبین; Anticoagulation; Anticoagulant protocols; Heparin; Low-molecular-weight heparin; Direct thrombin inhibitors; Bleeding;
New developments in parenteral anticoagulation for arterial and venous thromboembolism
Keywords: مهار کننده های مستقیم ترومبین; anticoagulants; parenteral; direct thrombin inhibitors; pentasaccharides; thrombosis
New Anticoagulants (Dabigatran, Apixaban, Rivaroxaban) for Stroke Prevention in Atrial Fibrillation
Keywords: مهار کننده های مستقیم ترومبین; Anticoagulation; Stroke; Atrial fibrillation; Reversal; Direct thrombin inhibitors; Factor Xa inhibitors; Dabigatran; Rivaroxaban; Apixaban; Edoxaban;
Les nouveaux anticoagulants oraux
Keywords: مهار کننده های مستقیم ترومبین; Inhibiteurs directs de la thrombine; Inhibiteurs directs du facteur X activé; Maladie thromboembolique; Fibrillation atriale; Patient âgé; Direct thrombin inhibitors; Direct factor Xa inhibitors; Thromboembolic disease; Atrial fibrillation; Elderly pat
Treatment, Survival, and Thromboembolic Outcomes of Thrombotic Storm in Children
Keywords: مهار کننده های مستقیم ترومبین; APA; Antiphospholipid antibody; APS; Antiphospholipid syndrome; β2GP1; β2-glycoprotein 1; CAPS; Catastrophic antiphospholipid antibody syndrome; CSVT; Cerebral sinovenous thrombosis; CTX; Cyclophosphamide; DTI; Direct thrombin inhibitors; DVT; Deep vein
New Oral Anticoagulants for Atrial Fibrillation: A Review of Clinical Trials
Keywords: مهار کننده های مستقیم ترومبین; anticoagulants; apixaban; dabigatran; direct thrombin inhibitors; factor Xa inhibitors; rivaroxaban
Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: A review of the literature
Keywords: مهار کننده های مستقیم ترومبین; VTE, venous thromboembolism; PE, pulmonary embolism; TKR, total knee replacement; THR, total hip replacement; DVT, deep vein thrombosisanticoagulant therapy; antithrombotic therapy; anticoagulants; direct thrombin inhibitors; factor Xa inhibitors
The promise of novel direct oral anticoagulants
Keywords: مهار کننده های مستقیم ترومبین; thromboembolism; new anticoagulants; direct thrombin inhibitors; factor Xa inhibitors
Factor Xa and thrombin as targets for new oral anticoagulants
Keywords: مهار کننده های مستقیم ترومبین; Anticoagulants; Arterial thromboembolism; Direct factor Xa inhibitors; Direct thrombin inhibitors; Venous thromboembolism;
The Influence of Direct Thrombin Inhibitors on the Formation of Platelet-leukocyte Aggregates and Tissue Factor Expression
Keywords: مهار کننده های مستقیم ترومبین; Direct thrombin inhibitors; Myocardial infarction; Platelet-monocyte aggregates; Tissue factor
Systemic Anticoagulation Considerations in Chronic Kidney Disease
Keywords: مهار کننده های مستقیم ترومبین; Hemodialysis; Chronic kidney disease; Anticoagulation; Warfarin; Low-molecular-weight heparin; Heparin; Direct thrombin inhibitors;
The Thrombin Hypothesis in ACS: A Disappointing Disconnect between Bench Data and Bedside Clinical Trials
Keywords: مهار کننده های مستقیم ترومبین; Acute coronary syndrome; Direct thrombin inhibitors; Factor Xa inhibitors
New oral anticoagulants to revolutionise venous thromboembolism (VTE) management
Keywords: مهار کننده های مستقیم ترومبین; Blood clotting cascade; Direct thrombin inhibitors; Deep vein thrombosis; Venous thromboembolism; Oral anticoagulant; Warfarin; Ximelagatran; Dabigatran etexilate; Rivaroxaban; Low molecular weight heparin; Enoxaparin; Direct factor Xa inhibitor
Pharmacokinetics and pharmacodynamics of the new oral anticoagulants
Keywords: مهار کننده های مستقیم ترومبین; Anticoagulants; Direct thrombin inhibitors; Direct factor Xa inhibitors; Pharmacokinetics; Pharmacodynamics; Anticoagulantes; Inhibidores directos de la trombina; Inhibidores directos del factor Xa; Farmacocinética; Farmacodinamia;
Farmacocinética y farmacodinamia de los nuevos anticoagulantes orales
Keywords: مهار کننده های مستقیم ترومبین; Anticoagulantes; Inhibidores directos de la trombina; Inhibidores directos del factor Xa; Farmacocinética; Farmacodinamia; Anticoagulants; Direct thrombin inhibitors; Direct factor Xa inhibitors; Pharmacokinetics; Pharmacodynamics;
Anticoagulation Monitoring
Keywords: مهار کننده های مستقیم ترومبین; Warfarin; Heparin; Low-molecular-weight heparin; Direct thrombin inhibitors; Xa inhibitors; Non-standardized coagulation testing; Reagent variability
Drugs affecting coagulation
Keywords: مهار کننده های مستقیم ترومبین; direct thrombin inhibitors; fondaparinux; glycoprotein IIb/IIIa antagonists; heparin; warfarin
Ximelagatran/melagatran against conventional anticoagulation: A meta-analysis based on 22,639 patients
Keywords: مهار کننده های مستقیم ترومبین; Conventional anticoagulants; Deep vein thrombosis; Direct thrombin inhibitors; Meta-analysis; Thromboembolic stroke
Bivalirudin in Peripheral Interventions
Keywords: مهار کننده های مستقیم ترومبین; bivalirudin; peripheral interventions; direct thrombin inhibitors
Transition to an Oral Anticoagulant in Patients With Heparin-Induced Thrombocytopenia
Keywords: مهار کننده های مستقیم ترومبین; coumarin derivative; direct thrombin inhibitors; heparin-induced thrombocytopenia; indanedione derivative; oral anticoagulants; venous limb gangrene; warfarin-induced skin necrosis; DTI; direct thrombin inhibitor; HIT; heparin-induced thrombocytopenia; IN
Anticoagulants in the treatment of deep vein thrombosis
Keywords: مهار کننده های مستقیم ترومبین; Deep vein thrombosis; Direct thrombin inhibitors; Low-molecular-weight heparin; Unfractionated heparin; Venous thromboembolism; Warfarin;
Heparin-induced thrombocytopenia: clinical manifestations and management strategies
Keywords: مهار کننده های مستقیم ترومبین; Deep vein thrombosis; Direct thrombin inhibitors; Heparin-induced thrombocytopenia type II; Low-molecular-weight heparin; Pulmonary embolism; Unfractionated heparin;